Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 14, No 2 (2021) Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis Abstract  similar documents
A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova
"... Objective: to perform cost-effectiveness analysis of the treatment for adult patients ..."
 
Vol 16, No 4 (2023) Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma Abstract  similar documents
S. V. Nedogoda, A. S. Salasyuk, S. N. Avdeev, I. N. Barykina, V. O. Lutova, E. A. Popova
 
Vol 13, No 2 (2020) Affordability of in vivo gene therapy. Problems and potential solutions Abstract  similar documents
V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko
 
Vol 16, No 3 (2023) Cost-effectiveness analysis of encorafenib and binimetinib combination as first-line treatment for metastatic or unresectable BRAF V600-mutated metastatic melanoma in Russia Abstract  similar documents
N. A. Avxentyev, Yu. V. Makarova
"... Objective: to perform a cost-effectiveness analysis of using encorafenib and binimetinib ..."
 
Vol 15, No 1 (2022) Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation Abstract  similar documents
T. O. Bessonova, F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova, V. V. Omelyanovskiy, S. N. Krivolapov, N. M. Neminushchiy, A. A. Kalemberg
 
Vol 15, No 1 (2022) Pharmacoeconomic analysis of using Monofer in patients with iron deficiency anemia as part of the provision of medical care under the state guarantees program in the health care system of the Russian Federation Abstract  similar documents
R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, O. A. Gromova, I. Yu. Torshin
 
Vol 15, No 3 (2022) Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis Abstract  similar documents
А. V. Kukurika
 
Vol 16, No 4 (2023) Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C Abstract  similar documents
I. A. Narkevich, E. A. Tsitlionok
 
Vol 14, No 3 (2021) An economic evaluation of pre-dialysis stage of chronic kidney disease Abstract  similar documents
E. I. Rumiantseva, M. V. Avxentyeva
 
Vol 14, No 3 (2021) Pharmacoeconomic analysis of the application of strong opioids for the treatment of chronic pain syndrome in patients with pancreatic cancer Abstract  similar documents
O. P. Bobrova, S. K. Zyryanov, N. A. Shnayder, M. M. Petrova
 
Vol 16, No 2 (2023) Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy Abstract  similar documents
M. V. Zhuravleva, V. P. Chulanov, Yu. V. Gagarina, E. A. Shabalina
 
Vol 16, No 3 (2023) Comparative analysis of using atezolizumab vs. durvalumab in combination with platinum-containing chemotherapy in adult patients with advanced small cell lung cancer Abstract  similar documents
I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova
"... . Pharmacoeconomic cost-effectiveness analysis, sensitivity analysis of the selected model to changes in its initial ..."
 
Vol 14, No 2 (2021) Clinical and economic analysis of using the thrombodynamics test in patients undergoing treatment with assisted reproductive technologies in the Russian Federation Abstract  similar documents
D. G. Shchurov, V. S. Dombrovskiy
 
Vol 16, No 2 (2023) Сlinical and economic evaluation of various etiotropic chemotherapy regimens in patients with respiratory tuberculosis with multidrug and extensively drug resistance Abstract  similar documents
N. Yu. Nikolenko, D. A. Kudlay, S. E. Borisov, T. E. Sannikova, N. P. Doktorova
 
Vol 13, No 2 (2020) Pharmacoeconomic analysis of tiotropium bromide and olodaterol fixed combination as maintenance therapy for patients with COPD in the Russian Federation Abstract  similar documents
S. V. Nedogoda, M. Yu. Frolov, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova
 
Vol 16, No 2 (2023) Comparative pharmacoeconomic analysis of follitropin delta application for superovulation induction during artificial insemination Abstract  similar documents
I. S. Krysanov, V. S. Krysanova, V. Yu. Ermakova
"... )), the cost-effectiveness analysis was used. The cost analysis included only direct medical costs: drugs ..."
 
1 - 16 of 16 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)